Yang GF - Search Results

1

A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer.

He WP, Chen YY, Wu LX, Guo YY, You ZS, Yang GF. He WP, et al. Among authors: yang gf. Front Immunol. 2022 Nov 16;13:1018544. doi: 10.3389/fimmu.2022.1018544. eCollection 2022. Front Immunol. 2022. PMID: 36466815 Free PMC article.

2

Expression and clinical significance of YKL-40 protein in epithelial ovarian cancer tissues.

Yang GF, Cai PY, Li XM, Deng HX, He WP, Xie D. Yang GF, et al. Ai Zheng. 2009 Feb;28(2):142-5. Epub 2009 Feb 11. Ai Zheng. 2009. PMID: 19550125 Free article.

3

Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma.

Cai MY, Zhang B, He WP, Yang GF, Rao HL, Rao ZY, Wu QL, Guan XY, Kung HF, Zeng YX, Xie D. Cai MY, et al. Among authors: yang gf. Cancer Sci. 2010 Jun;101(6):1543-9. doi: 10.1111/j.1349-7006.2010.01560.x. Epub 2010 Mar 10. Cancer Sci. 2010. PMID: 20367640 Free PMC article.

4

Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma.

Yang GF, He WP, Cai MY, He LR, Luo JH, Deng HX, Guan XY, Zeng MS, Zeng YX, Xie D. Yang GF, et al. BMC Cancer. 2010 Apr 8;10:133. doi: 10.1186/1471-2407-10-133. BMC Cancer. 2010. PMID: 20377880 Free PMC article.

5

Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma.

Yang G, He W, Cai M, Luo F, Kung H, Guan X, Zeng Y, Xie D. Yang G, et al. Int J Gynecol Cancer. 2011 Apr;21(3):486-93. doi: 10.1097/IGC.0b013e31820fa168. Int J Gynecol Cancer. 2011. PMID: 21436696

6

CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival.

He WP, Zhou J, Cai MY, Xiao XS, Liao YJ, Kung HF, Guan XY, Xie D, Yang GF. He WP, et al. Among authors: yang gf. BMC Cancer. 2012 Sep 29;12:437. doi: 10.1186/1471-2407-12-437. BMC Cancer. 2012. PMID: 23020525 Free PMC article.

7

Epigenetic and immunohistochemical characterization of the Clusterin gene in ovarian tumors.

Yang G, Zhang H, Liu Y, Zhou J, He W, Quick CM, Xie D, Smoller BR, Fan CY. Yang G, et al. Arch Gynecol Obstet. 2013 May;287(5):989-95. doi: 10.1007/s00404-012-2650-6. Epub 2012 Dec 4. Arch Gynecol Obstet. 2013. PMID: 23208459

8

Overexpression of clusterin promotes angiogenesis via the vascular endothelial growth factor in primary ovarian cancer.

Fu Y, Lai Y, Wang Q, Liu X, He W, Zhang H, Fan C, Yang G. Fu Y, et al. Mol Med Rep. 2013 Jun;7(6):1726-32. doi: 10.3892/mmr.2013.1436. Epub 2013 Apr 23. Mol Med Rep. 2013. PMID: 23616046

9

Lentivirus-mediated shRNA interference of clusterin blocks proliferation, motility, invasion and cell cycle in the ovarian cancer cells.

Fu Y, Lai Y, Liu J, Liu X, You Z, Yang G. Fu Y, et al. J Ovarian Res. 2015 Aug 21;8:59. doi: 10.1186/s13048-015-0173-z. J Ovarian Res. 2015. PMID: 26293319 Free PMC article.

10

Decreased expression of H3K27me3 in human ovarian carcinomas correlates with more aggressive tumor behavior and poor patient survival.

He WP, Li Q, Zhou J, H ZS, Kung HF, Guan XY, Xie D, Yang GF. He WP, et al. Among authors: yang gf. Neoplasma. 2015;62(6):932-7. doi: 10.4149/neo_2015_113. Neoplasma. 2015. PMID: 26458314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

407 results

Search Page

Filters